-
Sumac, Linalool, Eugenol Fight Cutaneous Leishmaniasis
16 Dec 2025 12:35 GMT
… integrated phytochemical and pharmacological methodologies. Advanced … escalates and new drug development struggles, accessible … of plantschallenges in treating cutaneous leishmaniasisdrug … extract for leishmaniasis treatmenttherapeutic alternatives for …
-
The Daily Pill Against Cancer, Heart Disease, and Dementia And Scores of Other Diseases
10 Dec 2025 04:21 GMT
… as we age or develop chronic diseases, our … adjunct to conventional RA treatments.
10. Exercise Performance … pharmacokinetics and safety profile make it compatible with virtually all medications … and fungal infections. For leishmaniasis (a parasitic disease), …
-
Advances in Pharmacological Activities, Biosynthesis, and Structural Modification of Ursodeoxycholic Acid (UDCA): A Review
05 Dec 2025 08:40 GMT
… pharmacological activities, UDCA still has key limitations in drug development … treat liver diseases. The development of liver specific NO releasing drugs … employed medications for the treatment of treating intestinal … disease, and leishmaniasis—all triggered by …
-
School of Pharmacy Units Spotlight: Updates & Achievements From the Pharmacy Practice & Pharmaceutical Sciences Units
26 Nov 2025 11:10 GMT
… inform future antidote development. Using a cell … pharmacy, and entitled “Biogenically Synthesized Nanoparticles as Emerging Therapeutics for Leishmaniasis … safer, cost-effective treatments for Leishmania infections. … temporary change in FDA COVID vaccine …
-
PAHO and Ministry of Health Launch National Mass Drug Administration to Eliminate Lymphatic Filariasis in Guyana
13 Nov 2025 14:15 GMT
… If we give these three drugs, then the worms in … that every person gets these medications.”
Community Mobilization and Field … country who would want to develop Bigfoot,” he said. “ … also targets Chagas disease, leprosy, leishmaniasis, hepatitis C, and malaria.
…
-
Marine sponges could hold the key to new Leishmaniasis treatments
25 Sep 2025 10:21 GMT
… that could transform the treatment of leishmaniasis – a neglected tropical … .
Challenges in current treatments
Existing drugs such as antimonial compounds … in vitro pharmacokinetics before clinical development can begin.
Towards drug development and …
-
Groundbreaking discovery could transform leishmaniasis treatment
24 Sep 2025 10:58 GMT
… -Yasumoto from the Faculty of Pharmaceutical Sciences at Tokyo University of … promising compounds for the development of new treatments for leishmaniasis. "It may … to surpass existing drugs. Pathogens are constantly evolving, and drug resistance is …
-
Assessing Risk Factors for Visceral Leishmaniasis Outbreak in South Omo Zone, Southern Ethiopia: Implications for Tailored Intervention Strategies
06 Nov 2025 01:12 GMT
… -depth interview topics were developed and pretested to increase … EPRP), mis-management of drugs and insufficient health care … cultural and religious medications for treatment of visceral leishmaniasis. Even though, … global goals? Am JTrop Med Hyg. 2016;95(3 …
-
A Presumptive Case of Mucocutaneous and Visceral Leishmaniasis in Nonendemic Country
03 Nov 2025 10:37 GMT
… and Drug Administration (FDA)-approved drugs are … is a medication that fights … leishmaniasis.
Abbreviations
CL, Cutaneous leishmaniasis; CT, Computed tomography; FDA, Food and Drug … A. Cutaneous leishmaniasis: successful treatment with itraconazole. …
-
Prevention and control of leishmaniasis
24 Oct 2025 14:54 GMT
•°Introduction:
Leishmaniasis is a parasitic disease caused by the Leishmania parasite. This parasite typically lives in infected female phlebotomine sand flies. You can contract leishmaniasis from bite of an infected sand fly.
~Different leishmania …